APA (7th ed.) Citation

CA, F., HJC, M., O, E., HWW, A., W, I., TJC, W., . . . NJ, G. (2025). Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization. NEJM evidence, 4(6), EVIDoa2500012. https://doi.org/10.1056/EVIDoa2500012

Chicago Style (17th ed.) Citation

CA, Flynn, et al. "Mepolizumab for COPD with Eosinophilic Phenotype Following Hospitalization." NEJM Evidence 4, no. 6 (2025): EVIDoa2500012. https://doi.org/10.1056/EVIDoa2500012.

MLA (9th ed.) Citation

CA, Flynn, et al. "Mepolizumab for COPD with Eosinophilic Phenotype Following Hospitalization." NEJM Evidence, vol. 4, no. 6, 2025, p. EVIDoa2500012, https://doi.org/10.1056/EVIDoa2500012.